The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Pre-GMP Facility

Currently Under Development

Welcome to the Lund Stem Cell Center Pre-GMP Facility, a dedicated support center for developers of Advanced Therapeutic Medicinal Products (ATMPs) at Lund University.

A photo of vials.

About ATMPs in Lund:

ATMPs, defined by the European Medicine Agency (EMA) as "medicines based on genes, tissues, or cells for human use," open new frontiers in medical research, offering new solutions for challenging medical conditions.

In Sweden, Lund is a leading force in ATMP development. Data from the Sweden Bio pipeline highlights Lund as the second-largest hub, following Stockholm, for small and medium-sized enterprises (SMEs) actively engaged in ATMP work. Over 23 ATMP projects in various stages are underway at Lund Stem Cell Center, several already evolving into successful biotech companies.

Our Mission:

At the Pre-GMP Facility, we're committed to fostering innovation and collaboration within the Lund ATMP community. Our facility will provide expertise, advanced equipment, and process optimization to streamline the transition from early-stage development to GMP compliant manufacturing, reducing time and costs, and empowering scientists to bring their therapies to patients more efficiently.

Stay updated on our facility's progress and explore our website for information about Lund Stem Cell Center, our research endeavors, and valuable resources to support your ATMP development journey. We look forward to serving you soon at the Pre-GMP Facility and working together to push the boundaries of medical innovation, transforming the future of healthcare through ATMPs!

What we will help with:

From discovery to GMP-manufacture, we will help to:

  • Convert research protocols to Standard Operating Procedures (SOPs)
  • Conduct process-specific risk assessment
  • Provide advanced instruments for therapy manufacture
  • Designated manufacture space for process development
  • Training and tech transfer to Skåne University Hospital (SUS) GMP manufacturing unit
ATMP Pipeline Report 2024 Cover.

Lund Stem Cell Center ATMP Pipeline Report 2024

Lund Stem Cell Center ATMP Pipeline Report 2023

We want to hear from you!

We are conducting an ongoing future user survey and want to hear from you.

  • What therapies is your team investigating?
  • What support would accelerate development?
  • What advanced equipment could help you project succeed?

We are eager to tailor our services to best fit your needs.

No project is too early for a first consultation, free of charge.

Portrait of Elias Uhlin. Photo.

Contact:

Elias Uhlin, Ph.D.
Project Manager

Lund University
Faculty of Medicine
Department of Experimental Medical Science
Visiting address: Sölvegatan 19

Elias [dot] Uhlin [at] med [dot] lu [dot] se
www.lunduniversity.lu.se

Page manager: alexis [dot] bento_luis [at] med [dot] lu [dot] se | 6 Nov 2024